Redwood Pharma AB 9JV.F Stock
Redwood Pharma AB Price Chart
Redwood Pharma AB 9JV.F Financial and Trading Overview
| Redwood Pharma AB stock price | 0.2 EUR |
| Previous Close | 0.03 EUR |
| Open | 0.03 EUR |
| Bid | 0.03 EUR x N/A |
| Ask | 0.04 EUR x N/A |
| Day's Range | 0.03 - 0.03 EUR |
| 52 Week Range | 0.01 - 0.15 EUR |
| Volume | 10K EUR |
| Avg. Volume | 178 EUR |
| Market Cap | 3.62M EUR |
| Beta (5Y Monthly) | 0.47816 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
9JV.F Valuation Measures
| Enterprise Value | 3.23M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.069955155 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Redwood Pharma AB Stock Price History
| Beta (5Y Monthly) | 0.47816 |
| 52-Week Change | -75.51% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.15 EUR |
| 52 Week Low | 0.01 EUR |
| 50-Day Moving Average | 0.03 EUR |
| 200-Day Moving Average | 0.05 EUR |
9JV.F Share Statistics
| Avg. Volume (3 month) | 178 EUR |
| Avg. Daily Volume (10-Days) | 1K EUR |
| Shares Outstanding | 105.45M |
| Float | 104.24M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -64.68% |
| Return on Equity (ttm) | -115.027% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.248 |
| Book Value Per Share (mrq) | 0.446 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Redwood Pharma AB
| Country | Germany |
| State | N/A |
| City | Stockholm |
| Address | Ringvagen 100E |
| ZIP | 118 60 |
| Phone | N/A |
| Website | https://www.redwoodpharma.se |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Redwood Pharma AB engages in the development of ophthalmic pharmaceutical therapies for market needs. The company's lead development product is RP101, an eye drop that treats severe chronic dry eye disease in post-menopausal women. It uses IntelliGel, a supramolecular smart drug delivery system for development of topical formulation for ophthalmic uses, as well as for administration to the front of the eye. Redwood Pharma AB was incorporated in 2012 and is headquartered in Stockholm, Sweden.
Q&A For Redwood Pharma AB Stock
What is a current 9JV.F stock price?
Redwood Pharma AB 9JV.F stock price today per share is 0.2 EUR.
How to purchase Redwood Pharma AB stock?
You can buy 9JV.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Redwood Pharma AB?
The stock symbol or ticker of Redwood Pharma AB is 9JV.F.
Which industry does the Redwood Pharma AB company belong to?
The Redwood Pharma AB industry is Biotechnology.
How many shares does Redwood Pharma AB have in circulation?
The max supply of Redwood Pharma AB shares is 3.29M.
What is Redwood Pharma AB Price to Earnings Ratio (PE Ratio)?
Redwood Pharma AB PE Ratio is 0.00000000 now.
What was Redwood Pharma AB earnings per share over the trailing 12 months (TTM)?
Redwood Pharma AB EPS is 0 EUR over the trailing 12 months.
Which sector does the Redwood Pharma AB company belong to?
The Redwood Pharma AB sector is Healthcare.